Latest Breaking News On - Citryll board - Page 1 : comparemela.com

Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat autoimmune and autoinflammatory diseases, today announced that Dr. Paul Peter Tak, Citryll Board member since

Noord hollandGalvani bioelectronicsEva mulderEric meldrumSenda biosciencesPaul peterAlexander siebertEuropean alliance of associationsAcademy of medical sciencesTrophic communicationsLeiden university medical centerNetherlands society for rheumatologyTempero pharmaceuticalsGlobal development leaderAmsterdam university medical centerUniversity of california san diego